Mylan Pharmaceuticals Recalls Lot of Alprazolam Tablets

Mylan Pharmaceuticals Recalls Lot of Alprazolam Tablets

Mylan Pharmaceuticals Inc. is recalling one lot of alprazolam tablets due to the potential presence of foreign substance, which can cause infection. 

Alprazolam tables are indicated for the management of anxiety disorder, the short-term relief of symptoms of anxiety, and the treatment of panic disorder, with or without agoraphobia. Mental health medications are not uncommon in workers’ comp claims, especially if workplace injuries reduce physical function and cause mental stress.

The recall specifically targets a bottle of 500 USP C-IV 0.5 mg tablets of alprazolam, lot number 8082708, with an expiration date of September 2020, and an NDC of 0378-4003-05.

For further information, read the FDA’s recall notice.